Renal tubular dysfunction in patients with American cutaneous leishmaniasis

Kidney International

Volumn 80, Issue 10, 2011, Pages 1099-1106

  Oliveira, Rodrigo A ^a   Diniz, Lúcyo F B ^a   Teotônio, Leonardo O ^a   Lima, Cláudio G ^a   Mota, Rosa M S ^a   Martins, Alice ^a   Sanches, Talita R ^b   Seguro, Antônio C ^b   Andrade, Lúcia ^b   Silva Jr , Geraldo B ^a,c   Libório, Alexandre B ^c   Daher, Elizabeth F ^c,d  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF FORTALEZA   (Brazil)

^d Ministry of Education Brazil   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIMONY; AQUAPORIN 2; BICARBONATE; CALCIUM CHLORIDE; CREATINE; DESMOPRESSIN; PENDRIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN 3;

ADULT; AMERICAN; AMERICAN CUTANEOUS LEISHMANIASIS; ARTICLE; BICARBONATE BLOOD LEVEL; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; EXOSOME; FEMALE; GLOMERULAR DYSFUNCTION; HUMAN; HUMAN CELL; KIDNEY CONCENTRATING CAPACITY; KIDNEY FUNCTION; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN LEISHMANIASIS; UPREGULATION; URINARY DYSFUNCTION; URINE ACIDIFICATION; URINE LEVEL; URINE OSMOLALITY; URINE PH; WESTERN BLOTTING;

EID: 80255135570     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.251     Document Type: Article

References (43)

1. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199. (Pubitemid 29460458)
2. Roberts LJ, Handeman E, Foote SJ. Science, medicine and the future Leishmaniasis. Br Med J 2000; 321: 801-804.
3. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305-318. (Pubitemid 38842803)
4. David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatologic Therapy 2009; 22: 491-502.
5. Dutra M, Martinelli M, de Carvalho EM et al. Renal involvement in visceral leishmaniasis. Am J Kidney Dis 1985; 6: 22-27. (Pubitemid 15020967)
6. Salgado Filho N, Ferreira TM, Costa JM. Envolvimento da função renal em pacientes com leishmaniose visceral (calazar). Rev Soc Bras Med Trop 2003; 36: 217-221. (Pubitemid 36753344)
7. Chaigne V, Knefati Y, Lafarge R et al. A patient with visceral leishmaniasis and acute renal failure in necrotizing glomerulonephritis. Nephrologie 2004; 25: 179-183. (Pubitemid 39071134)
8. Duvic C, Nedelec G, Debord T et al. Important parasitic nephropathies: update from recent literature. Nephrologie 1999; 20: 65-74. (Pubitemid 29166104)
9. Councilman WT. Acute interstitial nephritis. J Experiment Med 1988; 3: 393-420.
10. Cucé LC, Belda Jr W, Dias W. Nephrotoxicity to Glucantimes in the treatment of leishmaniasis. Rev Inst Med Trop S Paulo 1990; 32: 249-251.
11. Duarte MI, Silva MR, Gotto H. Interstitial nephritis in human kala-azar. Trans R Soc Trop Med Hyg 1983; 77: 531-537.
12. Caravaca F, Munoz A, Pizarro JL et al. Acute renal failure in visceral leishmaniasis. Am J Nephrol 1991; 11: 350-352.
13. Oliveira MJ, Silva Júnior GB, Abreu KL et al. Risk factors for acute kidney injury in visceral leishmaniasis. Am J Trop Med Hyg 2010; 82: 449-453.
14. Lima Verde EM, Lima Verde FA, Lima Verde FA et al. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol 2007; 20: 432-438.
15. Rodrigues ML, Costa RS, Souza CS et al. Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis. Rev Inst Med Trop S Paulo 1999; 41: 1-5.
16. Sampaio RN, Paula CD, Sampaio JH et al. Avaliação da tolerância e nefrotoxicidade do antimonial pentavalente administrado na dose de 40mg Sbv/kg/dia por 30 dias na forma cutânea-mucosa de leishmaniose. Rev Soc Bras Med Trop 1997; 30: 457-467.
17. Balsan M, Fenech F. Acute renal failure in visceral leishmaniasis treated with sodium stibogluconate. Trans Royal Soc Trop Med Hyg 1992; 86: 515-516.
18. Sampaio RN, Veiga JPR, Limeira OM et al. Insuficiência renal aguda em leishmaniose tegumentar americana tratada com a associação de glucantime e alopurinol. Anais Brasileiros de Dermatologia 1991; 66: 133-134.
19. Veiga JP, Khanan R, Rosa TT et al. Pentavalent antimonial nephrotoxicity in the rat. Rev Inst Med Trop São Paulo 1990; 32: 304-309. (Pubitemid 20332670)
20. Schubach AO, Marzochi KB, Moreira JS et al. Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate. Rev Soc Bras Med Trop 2005; 38: 213-217. (Pubitemid 40675628)
21. Sassi A, Louzir H, Ben Salah A et al. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin Exp Immunol 1999; 116: 127-132. (Pubitemid 29170015)
22. Reed SG. Diagnosis of leishmaniasis. Clin Dermatol 1996; 24: 471-478. (Pubitemid 26327740)
23. Oliveira RA, Silva Jr GB, Souza CJ et al. Evaluation of renal function in leprosy: a study of 59 consecutive patients. Nephrol Dial Transplant 2008; 23: 256-262. (Pubitemid 351767379)
24. Veiga JP, Wolff ER, Sampaio RN et al. Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials. Lancet 1983; 3: 359.
25. Gagliardi AR, Veiga JP, Rosa TT et al. Pentavalent antimonial inhibition of the osmotic effect of oxytocin on the isolated toad bladDer. Braz J Med Bio Res 1985; 18: 567-571. (Pubitemid 16128269)
26. Lima Verde FAA, Lima Verde FA, Daher EF et al. Renal tubular dysfunction in human visceral leishmaniasis (Kala-azar). Clin Nephrol 2009; 71: 492-500.
27. Kanno K, Sassaki S, Hirata Y et al. Urinary excretion aquaporin-2 in patients with diabetes insipidus. N Engl J Med 1995; 332: 1540-1545.
28. Wen H, Frokiaer J, Kwon TH et al. Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway. J Am Soc Nephrol 1999; 10: 1416-1429. (Pubitemid 29297516)
29. Martin PY, Abraham WT, Leiming X et al. Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol 1999; 10: 2165-2170. (Pubitemid 29453494)
30. McKee JA, Kumar S, Ecelbarger CA et al. Detection of Na+ transporter proteins in urine. J Am Soc Nephrol 2000; 11: 2128-2132.
31. Klingenberg M. Membrane protein oligomeric structure and transport function. Nature 1981; 290: 449-454.
32. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal disease. J Am Soc Nephrol 2004; 15: 1677-1689. (Pubitemid 38822046)
33. Zhou H, Yuen PS, Pisitkun T et al. Collection, storage, preservation and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006; 69: 1471-1476.
34. Gonzales PA, Pisitkun T, Hofferti JD et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009; 20: 363-379.
35. Schuster VL. Function and regulation of collecting duct intercalated cells. Annu Rev Physiol 1993; 55: 267-288. (Pubitemid 23102133)
36. Petrovic S, Wang Z, Ma L et al. Regulation of the apical Cl-/HCO3 exchanger pendrin in rat cortical collecting duct in metabolic acidosis. Am J Physiol Renal Physiol 2003; 284: F103-F112. (Pubitemid 35471290)
37. Royaux IE, Wall SM, Karniski LP et al. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci USA 2001; 98: 4221-4226. (Pubitemid 32249925)
38. Mohebbi N, Mihailova M, Wagner CA. The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins. Am J Physiol Renal Physiol 2009; 297: F499-F509.
39. Tryding N, Sterner G, Berg B et al. Subcutaneous and intranasal administration of 1-deamino-8-d-arginine vasopressin in the assessment of renal concentration capacity. Nephron 1987; 45: 27-30. (Pubitemid 17201726)
40. Tryding N, Berg B, Ekman S. DDAVP test for renal concentration capacity. Scand J Urol Nephrol 1988; 22: 141-145.
41. Oster JR. A short duration renal acidification test using calcium chloride. Nephron 1975; 14: 281-292.
42. Hoffert JD, Nielsen J, Yu MJ et al. Dynamic of aquaporin-2 serine-261 phosphorylation in response to short-term vasopressin treatment in collecting duct. Am J Physiol Renal Physiol 2007; 292: F691-F700. (Pubitemid 46220538)
43. Gonzales PA, Pisitkun T, Hoffert JD et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009; 20: 363-379.